Heavy Menstrual Bleeding: A Whole-Team Approach-Recognition, Management and Referral in Primary Care (Virtual)

This meeting has been organised by CliniLink Ltd and is supported by pharmaceutical companies through sponsorship. The sponsors Exeltis and Organon were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting. Further information about the event and sponsorship can be found below

This symposium, Supporting Women's Health: Contraception, Pregnancy and Menopause, has been organised and fully funded by Exeltis UK Ltd. Exeltis UK Ltd has selected the speaker and developed the content.

Organon has sponsored the costs associated with the logistical arrangements of this meeting. As part of the sponsorship, Organon will present at the meeting in a dedicated promotional session. Organon did not have any input on the agenda beyond this session.


See Sponsors below

Heavy Menstrual Bleeding:
A Whole-Team Approach-Recognition, Management and Referral in Primary Care (Virtual)

WEBINAR
  • 1 CPD Point towards your portfolio
  • CPD Certificate to download
  • Appraisal-ready CPD entry - no write-up needed
  • Take-home lecture notes
  • Speaker: Dr. Manju Navani

£0.00

Log in to Book

WEBINAR

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: MS Teams



Event Agenda

TimeTopicSpeaker
19:00-19:05Welcome and IntroductionCliniLink
19:05-19:15Supporting Women's Health: Contraception, Pregnancy and Menopause

Promotional symposium sponsored and organised by Exeltis. This session will include discussion of Exeltis medicines.
Indy Pahal (Key Account Manager Exeltis)
19:15-19:45Understanding HMB — definition, what's new in NICE, causes, red flags, and when to examine and investigateDr Manju Navani
19:45-19:55Organon sponsored promotional presentation(Virtual)
Organon
19:55-20:25Managing HMB — investigations, when to refer, treatment options including progestogens, and patient resourcesDr Manju Navani
20:25-20:40Case Discussion and QuestionsDr Manju Navani

Learning Outcomes

By the end of this webinar, participants will be able to:

  • Define heavy menstrual bleeding (HMB) and recognise its impact on quality of life
  • Summarise the latest updates to NICE guidance on the assessment and management of HMB
  • Describe the common causes of HMB, from structural to non-structural aetiologies
  • Identify red flag symptoms that warrant urgent assessment or referral
  • Determine when examination and investigation are indicated in primary care
  • Select appropriate investigations and recognise when onward referral is required
  • Outline the treatment options for HMB, including the use of progestogens to stop heavy bleeding
  • Signpost patients to reliable resources to support shared decision-making
  • Apply learning to real-world practice through interactive case discussions and key take-home messages



Meet the Speaker

Dr. Manju Navani

Dr. Manju Navani is a menopause, contraception, and community gynaecology specialist with over 25 years of experience in women’s health. She holds fellowships from the RCOG and FSRH, and is an accredited trainer with the British Menopause Society. Dr. Navani led the NHS menopause service in Stockport for 16 years. She is also the author of the Greater Manchester Menopause Guidelines and holds the BMS Advanced Menopause Certificate

Symposium Sponsors

This symposium, Supporting Women's Health: Contraception, Pregnancy and Menopause, has been organised and fully funded by Exeltis UK Ltd. Exeltis UK Ltd has selected the speaker and developed the content.

Organon has sponsored the costs associated with the logistical arrangements of this meeting. As part of the sponsorship, Organon will present at the meeting in a dedicated promotional session. Organon did not have any input on the agenda beyond this session.

Event Sponsors

This meeting has been organised by CliniLink Ltd and is supported by pharmaceutical companies through sponsorship. The sponsors Exeltis and Organon were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting. Further information about the event and sponsorship can be found below